R&D, Pharmacovigilance & Regulatory Affairs_tr

Ar-Ge, Farmakovijilans ve Ruhsatlandırma İşleri

Yeni ilaç çözümleri araştırma, geliştirme, test etme ve piyasaya sürme. Geliştirme süreci 8 ila 10 yıl sürer ve 4 fazdan oluşur.

  • Ar-Ge, Farmakovijilans ve Ruhsatlandırma İşleri

    Yeni ilaç çözümleri araştırma, geliştirme, test etme ve piyasaya sürme. Geliştirme süreci 8 ila 10 yıl sürer ve 4 fazdan oluşur.

Başlık Konum Tarih Sort ascending Req ID
Sıfırla
INTERN - Patient Engagement
INTERN - Patient Engagement PARMA, IT 31 Ara 2025 5993
PARMA, IT 31 Ara 2025 5993
INTERN - Process Technologist
INTERN - Process Technologist Parma, IT 1 Oca 2026 6228
Parma, IT 1 Oca 2026 6228
Clinical Program Leader
Clinical Program Leader Europe - Remote, IT 4 Oca 2026 5902
Europe - Remote, IT 4 Oca 2026 5902
Pharmazeut (all genders) im Praktikum für 2026 / 2027 Hamburg, DE 8 Oca 2026 351
Statistical Programmer
Statistical Programmer Europe - remote, FR 9 Oca 2026 6151
Europe - remote, FR 9 Oca 2026 6151
INTERN - Traslational Chemistry & Technology Innovation Lab Tech Parma, IT 10 Oca 2026 6338
Translational and Precision Medicine Lead
Translational and Precision Medicine Lead Europe - remote, GB 10 Oca 2026 6152
Europe - remote, GB 10 Oca 2026 6152
Senior Director, Clinical Biometrics & Analytics Parma, IT 14 Oca 2026 6387
Intern, Regulatory Affairs, Global Rare Diseases - Summer 2026 Cary, NC, US 16 Oca 2026 6413
Senior Clinical Research Physician Non-Obstructive Respiratory Diseases UK, GB 16 Oca 2026 5448
Clinical Trial Documentation & Records Management Lead Parma, IT 17 Oca 2026 6428
Senior Director, Clinical Excellence AIR - Bronchiectasis & Non-obstructive Lung Diseases Europe, IT 18 Oca 2026 6111
Senior Director, Global Patient Safety Science
Senior Director, Global Patient Safety Science Everywhere in Europe, IT 19 Oca 2026 6078
Everywhere in Europe, IT 19 Oca 2026 6078
R&D Manufacturing & Technology Transfer Manager Parma, IT 20 Oca 2026 6501
Sr. Manager, CMC Regulatory Affairs
Sr. Manager, CMC Regulatory Affairs United States, US 22 Oca 2026 6204
United States, US 22 Oca 2026 6204
Clinical Program Leader, R&D Global Rare Diseases
Clinical Program Leader, R&D Global Rare Diseases Europe - remote, GB 23 Oca 2026 6146
Europe - remote, GB 23 Oca 2026 6146
Sr. Director, Clinical Programs, Global Rare Diseases Boston, MA, US 24 Oca 2026 6205